Ibrahim Usman-Oyowe, MD
Physical Medicine & Rehabilitation · Chicago, ILNPI 1255695136
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,303 of the $10,015 with a category attached, or 62.9%. 30 manufacturers reported payments, led by Nevro Corp. at 50.5% of the total. Reporting peaked in 2019 at $2,878 and has fallen 68.4% since, to $909 in 2025. Among physical medicine & rehabilitation clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 214 payments — averaging $46.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$5K
- Abbott$1K
- SPR Therapeutics, Inc$1K
- Si-bone, Inc.$855
- Stryker$327
- Globus Medical$282
- plus $1K from 24 others
What the payments were for
- Travel & lodging$3,71337%
- Food & beverage$6,30363%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 99 | $5,058 |
| Abbott | 25 | $1,215 |
| SPR Therapeutics, Inc | 8 | $1,030 |
| Si-bone, Inc. | 15 | $855 |
| Stryker | 2 | $327 |
| Globus Medical | 12 | $282 |
| Boston Scientific | 5 | $225 |
| Radius Health, Inc. | 6 | $119 |
| Painteq LLC | 5 | $96 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $93 |
| Averitas Pharma Inc. | 3 | $90 |
| Collegium Pharmaceutical, Inc. | 4 | $66 |
| Valinor Pharma, LLC | 3 | $53 |
| Stimwave Technologies Incorporated | 1 | $51 |
| Medtronic | 2 | $48 |
| Vertex | 2 | $47 |
| Curonix LLC | 1 | $46 |
| Tersera Therapeutics LLC | 2 | $38 |
| Amgen | 2 | $36 |
| Almatica Pharma LLC | 2 | $34 |
| Biotronik NRO, Inc. | 1 | $31 |
| Zimmer Biomet | 1 | $25 |
| Pacira Pharmaceuticals Incorporated | 1 | $25 |
| Flowonix Medical Incorporated | 1 | $23 |
| IBSA Pharma Inc. | 1 | $22 |
| Pacira Therapeutics, Inc. | 1 | $19 |
| Bioventus LLC | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Pfizer | 1 | $16 |
| Biodelivery Sciences International, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,015 in reported general payments places this provider in the 95th percentile of 433 physical medicine & rehabilitation providers in Illinois.
See all physical medicine & rehabilitation providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 72 | $164,327 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 2,077 | $67,462 |
| Xtampza ErOxycodone Myristate | 92 | $65,708 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,466 | $54,206 |
| LinzessLinaclotide | 87 | $46,984 |
| BelbucaBuprenorphine Hcl | 21 | $15,035 |
| Celecoxib | 719 | $14,064 |
| OxycontinOxycodone Hcl | 22 | $12,576 |
| Oxycodone Hcl | 540 | $11,198 |
| EliquisApixaban | 16 | $10,141 |
| Methocarbamol | 508 | $10,095 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $8,147 |
| Pregabalin | 471 | $7,054 |
| Buprenorphine | 26 | $6,803 |
| Gabapentin | 776 | $6,518 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $93 | $164,32772 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $66 | $80,743113 claims |
| PfizerEliquis | $16 | $10,14116 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 433 physical medicine & rehabilitation providers in Illinois.
Other physical medicine & rehabilitation in Chicago
- Zachary McCormickChicago$290K
- Ravi KasiChicago$17K
- Steven KreisChicago$16K
- Henry GuanChicago$11K
- Giuliana RotunnoChicago$5K
- Leon HuddlestonChicago$4K
- Alice YeChicago$4K
- Anjum KhanChicago$3K
- Jessica MaroneChicago$3K
- Allison Kessler VearChicago$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.